Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Effects of micro-porosity and local BMP-2 administration on bioresorption of β-TCP and new bone formation.

Kakuta A, Tanaka T, Chazono M, Komaki H, Kitasato S, Inagaki N, Akiyama S, Marumo K.

Biomater Res. 2019 Jul 26;23:12. doi: 10.1186/s40824-019-0161-2. eCollection 2019.

2.

Static Leukoencephalopathy Associated with 17p13.3 Microdeletion Syndrome: A Case Report.

Hirasawa-Inoue A, Takeshita E, Shimizu-Motohashi Y, Ishiyama A, Saito T, Komaki H, Nakagawa E, Sugai K, Inoue K, Goto YI, Sasaki M.

Neuropediatrics. 2019 Aug 1. doi: 10.1055/s-0039-1693972. [Epub ahead of print]

PMID:
31370080
3.

Single-fiber electromyography-based diagnosis of CACNA1A mutation in children: A potential role of the electrodiagnosis in the era of whole exome sequencing.

Hirasawa-Inoue A, Ishiyama A, Takeshita E, Shimizu-Motohashi Y, Saito T, Komaki H, Nakagawa E, Yuasa S, Saitsu H, Hamanaka K, Miyatake S, Matsumoto N, Sasaki M.

Brain Dev. 2019 Jul 6. pii: S0387-7604(19)30032-4. doi: 10.1016/j.braindev.2019.06.006. [Epub ahead of print]

PMID:
31288946
4.

Reclassification of Streptomyces rimosus subsp. paromomycinus as Streptomyces paromomycinus sp. nov.

Komaki H, Tamura T.

Int J Syst Evol Microbiol. 2019 Aug;69(8):2577-2583. doi: 10.1099/ijsem.0.003545. Epub 2019 Jun 21.

PMID:
31225792
5.

COX6A2 variants cause a muscle-specific cytochrome c oxidase deficiency.

Inoue M, Uchino S, Iida A, Noguchi S, Hayashi S, Takahashi T, Fujii K, Komaki H, Takeshita E, Nonaka I, Okada Y, Yoshizawa T, Van Lommel L, Schuit F, Goto YI, Mimaki M, Nishino I.

Ann Neurol. 2019 Aug;86(2):193-202. doi: 10.1002/ana.25517. Epub 2019 Jul 2.

PMID:
31155743
6.

Transfer of Streptomyces catbensis Sakiyama et al. 2014 and Streptomyces seranimatus Wang et al. 2012 to Yinghuangia catbensis comb. nov. and Yinghuangia seranimata comb. nov.

Komaki H, Tamura T.

Int J Syst Evol Microbiol. 2019 Aug;69(8):2263-2267. doi: 10.1099/ijsem.0.003458. Epub 2019 May 24.

PMID:
31125301
7.

Unusual manifestation of left ventricular electrical conduction delay on the surface 12-lead electrocardiogram in a patient with prior myocardial infarction.

Nakashima T, Takasugi N, Komaki H, Sahashi Y, Kubota T, Nishigaki K, Okura H.

J Electrocardiol. 2019 Jul - Aug;55:32-33. doi: 10.1016/j.jelectrocard.2019.04.015. Epub 2019 Apr 30.

PMID:
31078105
8.

Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride.

Takizawa H, Hara Y, Mizobe Y, Ohno T, Suzuki S, Inoue K, Takeshita E, Shimizu-Motohashi Y, Ishiyama A, Hoshino M, Komaki H, Takeda S, Aoki Y.

Sci Rep. 2019 Mar 7;9(1):3807. doi: 10.1038/s41598-019-40421-z.

9.

Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer's disease.

Komaki H, Faraji N, Komaki A, Shahidi S, Etaee F, Raoufi S, Mirzaei F.

Brain Res Bull. 2019 Apr;147:14-21. doi: 10.1016/j.brainresbull.2019.01.025. Epub 2019 Feb 2.

PMID:
30721766
10.

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches.

Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda S, Yokota T, Aoki Y.

J Pers Med. 2019 Jan 7;9(1). pii: E1. doi: 10.3390/jpm9010001. Review.

11.

A phase I study of TAS-205 in patients with Duchenne muscular dystrophy.

Takeshita E, Komaki H, Shimizu-Motohashi Y, Ishiyama A, Sasaki M, Takeda S.

Ann Clin Transl Neurol. 2018 Oct 10;5(11):1338-1349. doi: 10.1002/acn3.651. eCollection 2018 Nov.

12.

Isolation and structure determination of a new lasso peptide specialicin based on genome mining.

Kaweewan I, Hemmi H, Komaki H, Harada S, Kodani S.

Bioorg Med Chem. 2018 Dec 15;26(23-24):6050-6055. doi: 10.1016/j.bmc.2018.11.007. Epub 2018 Nov 9.

PMID:
30448257
13.

A Nationwide Survey on Danon Disease in Japan.

Sugie K, Komaki H, Eura N, Shiota T, Onoue K, Tsukaguchi H, Minami N, Ogawa M, Kiriyama T, Kataoka H, Saito Y, Nonaka I, Nishino I.

Int J Mol Sci. 2018 Nov 8;19(11). pii: E3507. doi: 10.3390/ijms19113507.

14.

NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy.

Watanabe N, Nagata T, Satou Y, Masuda S, Saito T, Kitagawa H, Komaki H, Takagaki K, Takeda S.

Mol Ther Nucleic Acids. 2018 Dec 7;13:442-449. doi: 10.1016/j.omtn.2018.09.017. Epub 2018 Sep 27.

15.

Isolation and structure determination of a new cytotoxic peptide, curacozole, from Streptomyces curacoi based on genome mining.

Kaweewan I, Komaki H, Hemmi H, Hoshino K, Hosaka T, Isokawa G, Oyoshi T, Kodani S.

J Antibiot (Tokyo). 2019 Jan;72(1):1-7. doi: 10.1038/s41429-018-0105-4. Epub 2018 Oct 11.

PMID:
30310179
16.

Azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in spontaneously hypertensive rats.

Komaki H, Iwasa M, Hayakawa Y, Okamoto C, Minatoguchi S, Yamada Y, Kanamori H, Kawasaki M, Nishigaki K, Minatoguchi S.

Hypertens Res. 2018 Nov;41(11):886-896. doi: 10.1038/s41440-018-0099-0. Epub 2018 Sep 12.

PMID:
30209283
17.

Streptopeptolin, a Cyanopeptolin-Type Peptide from Streptomyces olivochromogenes.

Kodani S, Komaki H, Hemmi H, Miyake Y, Kaweewan I, Dohra H.

ACS Omega. 2018 Jul 31;3(7):8104-8110. doi: 10.1021/acsomega.8b01042. Epub 2018 Jul 19.

18.

A novel LMNA mutation identified in a Japanese patient with LMNA-associated congenital muscular dystrophy.

Ishiyama A, Iida A, Hayashi S, Komaki H, Sasaki M, Nonaka I, Noguchi S, Nishino I.

Hum Genome Var. 2018 Jul 20;5:19. doi: 10.1038/s41439-018-0018-6. eCollection 2018.

19.

Quantitative Analysis of Surface Electromyography for Pediatric Neuromuscular Disorders.

Higashihara M, Sonoo M, Ishiyama A, Nagashima Y, Matsumoto K, Uesugi H, Mori-Yoshimura M, Murata M, Murayama S, Komaki H.

Muscle Nerve. 2018 Dec;58(6):824-827. doi: 10.1002/mus.26299. Epub 2018 Oct 17.

PMID:
30019482
20.

Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers.

Takeshita E, Komaki H, Tachimori H, Miyoshi K, Yamamiya I, Shimizu-Motohashi Y, Ishiyama A, Saito T, Nakagawa E, Sugai K, Sasaki M.

Brain Dev. 2018 Nov;40(10):918-925. doi: 10.1016/j.braindev.2018.06.012. Epub 2018 Jul 10.

PMID:
30006121
21.

Linfuranones B and C, Furanone-Containing Polyketides from a Plant-Associated Sphaerimonospora mesophila.

Akiyama H, Indananda C, Thamchaipenet A, Motojima A, Oikawa T, Komaki H, Hosoyama A, Kimura A, Oku N, Igarashi Y.

J Nat Prod. 2018 Jul 27;81(7):1561-1569. doi: 10.1021/acs.jnatprod.8b00071. Epub 2018 Jun 25.

PMID:
29939741
22.

Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis.

Shimizu-Motohashi Y, Murakami T, Kimura E, Komaki H, Watanabe N.

Orphanet J Rare Dis. 2018 Jun 15;13(1):93. doi: 10.1186/s13023-018-0834-2.

23.

Seizure imitators monitored using video-EEG in children with intellectual disabilities.

Ueda R, Shimizu-Motohashi Y, Sugai K, Takeshita E, Ishiyama A, Saito T, Komaki H, Nakagawa E, Sasaki M.

Epilepsy Behav. 2018 Jul;84:122-126. doi: 10.1016/j.yebeh.2018.05.006. Epub 2018 May 20.

PMID:
29791879
24.

Interpretation of acid α-glucosidase activity in creatine kinase elevation: A case of Becker muscular dystrophy.

Oitani Y, Ishiyama A, Kosuga M, Iwasawa K, Ogata A, Tanaka F, Takeshita E, Shimizu-Motohashi Y, Komaki H, Nishino I, Okuyama T, Sasaki M.

Brain Dev. 2018 Oct;40(9):837-840. doi: 10.1016/j.braindev.2018.05.001. Epub 2018 May 16.

PMID:
29778277
25.

CO2-sensitive tRNA modification associated with human mitochondrial disease.

Lin H, Miyauchi K, Harada T, Okita R, Takeshita E, Komaki H, Fujioka K, Yagasaki H, Goto YI, Yanaka K, Nakagawa S, Sakaguchi Y, Suzuki T.

Nat Commun. 2018 May 14;9(1):1875. doi: 10.1038/s41467-018-04250-4.

26.

Diversity of nonribosomal peptide synthetase and polyketide synthase gene clusters among taxonomically close Streptomyces strains.

Komaki H, Sakurai K, Hosoyama A, Kimura A, Igarashi Y, Tamura T.

Sci Rep. 2018 May 2;8(1):6888. doi: 10.1038/s41598-018-24921-y.

27.

Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy.

Komaki H, Nagata T, Saito T, Masuda S, Takeshita E, Sasaki M, Tachimori H, Nakamura H, Aoki Y, Takeda S.

Sci Transl Med. 2018 Apr 18;10(437). pii: eaan0713. doi: 10.1126/scitranslmed.aan0713.

PMID:
29669851
28.

Decarboxylation of indomethacin induced by heat treatment.

Shimada Y, Komaki H, Hirai A, Goto S, Hashimoto Y, Uchiro H, Terada H.

Int J Pharm. 2018 Jul 10;545(1-2):51-56. doi: 10.1016/j.ijpharm.2018.04.022. Epub 2018 Apr 13.

PMID:
29660474
29.

Radiofrequency catheter ablation for ventricular tachycardia in ischaemic cardiomyopathy due to Kawasaki disease.

Komaki H, Nakashima T, Minatoguchi S.

Cardiol Young. 2018 Jun;28(6):890-893. doi: 10.1017/S1047951118000471. Epub 2018 Apr 16.

PMID:
29656721
30.

Reclassification of Nocardia species based on whole genome sequence and associated phenotypic data.

Tamura T, Ohji S, Ichikawa N, Hosoyama A, Yamazoe A, Hamada M, Komaki H, Shibata C, Matsuzawa T, Gonoi T, Suzuki KI, Fujita N.

J Antibiot (Tokyo). 2018 Jul;71(7):633-641. doi: 10.1038/s41429-018-0043-1. Epub 2018 Apr 4.

PMID:
29618770
31.

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation.

Mori-Yoshimura M, Mitsuhashi S, Nakamura H, Komaki H, Goto K, Yonemoto N, Takeuchi F, Hayashi YK, Murata M, Takahashi Y, Nishino I, Takeda S, Kimura E.

J Neuromuscul Dis. 2018;5(2):193-203. doi: 10.3233/JND-170225.

32.

Draft genome sequence of Streptomyces hyaluromycini MB-PO13T, a hyaluromycin producer.

Harunari E, Komaki H, Ichikawa N, Hosoyama A, Kimura A, Hamada M, Igarashi Y.

Stand Genomic Sci. 2018 Jan 11;13:2. doi: 10.1186/s40793-017-0286-7. eCollection 2018.

33.

NDUFAF3 variants that disrupt mitochondrial complex I assembly may associate with cavitating leukoencephalopathy.

Ishiyama A, Muramatsu K, Uchino S, Sakai C, Matsushima Y, Makioka N, Ogata T, Suzuki E, Komaki H, Sasaki M, Mimaki M, Goto YI, Nishino I.

Clin Genet. 2018 May;93(5):1103-1106. doi: 10.1111/cge.13215. Epub 2018 Feb 11.

PMID:
29344937
34.

Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats.

Okamoto C, Hayakawa Y, Aoyama T, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kanamori H, Kawasaki M, Nishigaki K, Mikami A, Minatoguchi S.

PLoS One. 2017 Dec 8;12(12):e0189099. doi: 10.1371/journal.pone.0189099. eCollection 2017.

35.

A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy.

Goemans N, Mercuri E, Belousova E, Komaki H, Dubrovsky A, McDonald CM, Kraus JE, Lourbakos A, Lin Z, Campion G, Wang SX, Campbell C; DEMAND III study group.

Neuromuscul Disord. 2018 Jan;28(1):4-15. doi: 10.1016/j.nmd.2017.10.004. Epub 2017 Dec 6.

36.

Duchenne muscular dystrophy with platypnea-orthodeoxia from Chilaiditi syndrome.

Ogasawara M, Ishiyama A, Sugiura A, Segawa K, Nonaka I, Takeshita E, Shimizu-Motohashi Y, Komaki H, Sasaki M.

Brain Dev. 2018 Apr;40(4):339-342. doi: 10.1016/j.braindev.2017.11.001. Epub 2017 Nov 20.

PMID:
29157800
37.

Cardiac conduction disturbances and aging in patients with Duchenne muscular dystrophy.

Segawa K, Komaki H, Mori-Yoshimura M, Oya Y, Kimura K, Tachimori H, Kato N, Sasaki M, Takahashi Y.

Medicine (Baltimore). 2017 Oct;96(42):e8335. doi: 10.1097/MD.0000000000008335.

38.

Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study.

Hama Y, Mori-Yoshimura M, Komaki H, Suzuki S, Kohsaka H, Nishino I, Takahashi Y.

Rinsho Shinkeigaku. 2017 Oct 27;57(10):567-572. doi: 10.5692/clinicalneurol.cn-001040. Epub 2017 Sep 30. Japanese.

PMID:
28966227
39.

3D electrochemical and ion current imaging using scanning electrochemical-scanning ion conductance microscopy.

Takahashi Y, Ida H, Matsumae Y, Komaki H, Zhou Y, Kumatani A, Kanzaki M, Shiku H, Matsue T.

Phys Chem Chem Phys. 2017 Oct 11;19(39):26728-26733. doi: 10.1039/c7cp05157c.

PMID:
28951914
40.

IBA57 mutations abrogate iron-sulfur cluster assembly leading to cavitating leukoencephalopathy.

Ishiyama A, Sakai C, Matsushima Y, Noguchi S, Mitsuhashi S, Endo Y, Hayashi YK, Saito Y, Nakagawa E, Komaki H, Sugai K, Sasaki M, Sato N, Nonaka I, Goto YI, Nishino I.

Neurol Genet. 2017 Sep 8;3(5):e184. doi: 10.1212/NXG.0000000000000184. eCollection 2017 Oct.

41.

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.

Okubo M, Goto K, Komaki H, Nakamura H, Mori-Yoshimura M, Hayashi YK, Mitsuhashi S, Noguchi S, Kimura E, Nishino I.

Orphanet J Rare Dis. 2017 Aug 31;12(1):149. doi: 10.1186/s13023-017-0703-4.

42.

A comparative study of care practices for young boys with Duchenne muscular dystrophy between Japan and European countries: Implications of early diagnosis.

Takeuchi F, Komaki H, Yamagata Z, Maruo K, Rodger S, Kirschner J, Kubota T, Kimura E, Takeda S, Gramsch K, Vry J, Bushby K, Lochmüller H, Wada K, Nakamura H.

Neuromuscul Disord. 2017 Oct;27(10):894-904. doi: 10.1016/j.nmd.2017.06.557. Epub 2017 Jul 6.

43.

Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status.

Miyagoe-Suzuki Y, Nishiyama T, Nakamura M, Narita A, Takemura F, Masuda S, Minami N, Murayama K, Komaki H, Goto YI, Takeda S.

Stem Cells Int. 2017;2017:7906843. doi: 10.1155/2017/7906843. Epub 2017 Apr 12.

44.

Basic research and clinical application of beta-tricalcium phosphate (β-TCP).

Tanaka T, Komaki H, Chazono M, Kitasato S, Kakuta A, Akiyama S, Marumo K.

Morphologie. 2017 Sep;101(334):164-172. doi: 10.1016/j.morpho.2017.03.002. Epub 2017 Apr 24.

PMID:
28462796
45.

The interactive role of CB1 receptors and L-type calcium channels in hippocampal long-term potentiation in rats.

Komaki H, Saadat F, Shahidi S, Sarihi A, Hasanein P, Komaki A.

Brain Res Bull. 2017 May;131:168-175. doi: 10.1016/j.brainresbull.2017.04.009. Epub 2017 Apr 23.

PMID:
28442324
46.

Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions.

Takeshita E, Minami N, Minami K, Suzuki M, Awashima T, Ishiyama A, Komaki H, Nishino I, Sasaki M.

Neuromuscul Disord. 2017 Jun;27(6):569-573. doi: 10.1016/j.nmd.2017.03.011. Epub 2017 Apr 3.

PMID:
28434908
47.

Biosynthetic origin of butyrolactol A, an antifungal polyketide produced by a marine-derived Streptomyces.

Harunari E, Komaki H, Igarashi Y.

Beilstein J Org Chem. 2017 Mar 8;13:441-450. doi: 10.3762/bjoc.13.47. eCollection 2017.

48.

Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.

Shiri M, Komaki A, Oryan S, Taheri M, Komaki H, Etaee F.

Can J Physiol Pharmacol. 2017 Apr;95(4):382-387. doi: 10.1139/cjpp-2016-0274. Epub 2016 Nov 2.

PMID:
28112976
49.

Draft Genome Sequence of an Anicemycin Producer, Streptomyces sp. TP-A0648.

Komaki H, Hosoyama A, Kimura A, Ichikawa N, Igarashi Y.

Genome Announc. 2017 Jan 12;5(2). pii: e01468-16. doi: 10.1128/genomeA.01468-16.

50.

Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice.

Matsuzaka Y, Tanihata J, Komaki H, Ishiyama A, Oya Y, Rüegg U, Takeda SI, Hashido K.

PLoS One. 2016 Dec 15;11(12):e0167811. doi: 10.1371/journal.pone.0167811. eCollection 2016.

Supplemental Content

Loading ...
Support Center